You just read:

AOP Orphan and PharmaEssentia announce latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera from 3 abstracts presented at the 22nd Congress of the European Hematology Association (EHA) in Madrid

News provided by

AOP Orphan Pharmaceuticals AG , PharmaEssentia Corporation

Jun 25, 2017, 06:00 ET